Imran Ahmad
33Patents
7h-index
35Co-inventors
69Inventor score
Filing activity: Feb 2, 1995 → Feb 9, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5631394A | Pharmaceutically active ceramide-related compounds | Emerging Cross-Sectional Technologies | 44 | Expired |
| US5677337A | Methods of treatment using pharmaceutically active ceramide-related compositions | Emerging Cross-Sectional Technologies | 21 | Expired |
| US6500461B2 | Particulate formulations | Human Necessities | 18 | Expired |
| US5942246A | Etherlipid containing multiple lipid liposomes | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6007839A | Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes | Emerging Cross-Sectional Technologies | 12 | Expired |
| US9333190B2 | Endoxifen compositions and methods | Chemistry; Metallurgy | 11 | Active |
| US6482850B2 | Hydrolysis-promoting hydrophobic taxane derivatives | Human Necessities | 10 | Expired |
| US7262173B2 | Chemosensitizing with liposomes containing oligonucleotides | Chemistry; Metallurgy | 7 | Expired |
| US6667053B1 | D and L etherlipid stereoisomers and liposomes | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5762958A | Multilipid component ether lipid liposomes | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5766624A | Liposomal defensins | Human Necessities | 7 | Expired |
| US5681589A | Liposomal ceramide-related liposomes and the therapeutic use thereof | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6107332A | Hydrolysis-promoting hydrophobic taxane derivatives | Human Necessities | 4 | Expired |
| US7122553B2 | Liposomal formulation of irinotecan | Human Necessities | 3 | Expired |
| US10376479B2 | Endoxifen compositions and methods | Chemistry; Metallurgy | 3 | Active |
| US5965159A | Etherlipid-containing multiple lipid liposomes | Emerging Cross-Sectional Technologies | 3 | Expired |
| US11291640B2 | Endoxifen for the treatment of bipolar I disorder | Human Necessities | 1 | Active |
| US9750812B2 | Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US6392063B1 | Hydrolysis-promoting hydrophobic taxane derivatives | Human Necessities | 0 | Expired |
| US12390832B2 | UV curing system with UV lamp trolley system | Performing Operations; Transporting | 0 | Active |
| US7138512B2 | Gene SHINC-2 and diagnostic and therapeutic uses thereof | Human Necessities | 0 | Expired |
| US7442520B2 | Gene BRCC-3 and diagnostic and therapeutic uses thereof | Chemistry; Metallurgy | 0 | Expired |
| US6180137A | Etherlipid-containing multiple lipid liposomes | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9637515B2 | Guggulphospholipid methods and compositions | Chemistry; Metallurgy | 0 | Active |
| US8298573B2 | Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.